Phase I combination study of trabectedin (T) and capecitabine (C) in patients with advanced malignancies.

被引：0
|
作者：
Gore, L.
Rivera, E.
Lavallee, K.
Holden, S.
Grolnic, S.
Cleere, D.
Moulder, S. L.
Elsayed, Y. A.
Eckhardt, S.
机构：
[1] Univ Colorado, Aurora, CO USA
[2] Johnson & Johnson Pharmaceut R&D, Raritan, NJ USA
[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：98S / 98S
页数：1
相关论文
共 50 条
  • [1] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Lia Gore
    E. Rivera
    M. Basche
    S. L. Moulder-Thompson
    J. Li
    S. Eppers
    S. Grolnic
    C. O’Bryant
    D. Cleere
    Y. A. Elsayed
    S. G. Eckhardt
    [J]. Investigational New Drugs, 2012, 30 : 1942 - 1949
  • [2] Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
    Gore, Lia
    Rivera, E.
    Basche, M.
    Moulder-Thompson, S. L.
    Li, J.
    Eppers, S.
    Grolnic, S.
    O'Bryant, C.
    Cleere, D.
    Elsayed, Y. A.
    Eckhardt, S. G.
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1942 - 1949
  • [3] Phase I study of trabectedin (T) in combination with docetaxel (D) in patients with advanced malignancies.
    Von Mehren, M.
    Buck, D.
    Temmer, E.
    Elsayed, Y. A.
    Cohen, R. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 96S - 96S
  • [4] A phase I Study of ecteinascidin 743(E) and capecitabine (C) in patients (pts) with advanced solid malignancies.
    Holden, SN
    Rivera, E
    Basche, M
    Gore, L
    Raj, SKS
    O'Bryant, CL
    Grolnic, S
    Hunt, J
    Brillhart, B
    Van de Velde, H
    Roberts, D
    Rodgers, J
    Eckhardt, SG
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6080S - 6080S
  • [5] A phase I trial of the mTOR inhibitor temsirolimus (TEM) in combination with capecitabine (CAP) in patients with advanced malignancies.
    Pishvaian, Michael J.
    Wang, Hongkun
    Hardesty, Rosemarie A.
    Deeken, John F.
    He, Aiwu Ruth
    Subramaniam, Deepa Suresh
    Zhuang, Tingting
    McCarthy, Damian L.
    Melville, Heather
    Albanese, Christopher
    Marshall, John
    Hwang, Jimmy J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Brequinar in combination with cisplatin in patients with advanced malignancies. A phase I study with pharmacokinetics
    Burris, A
    Raymond, E
    Awada, A
    Kuhn, J
    O'Rourke, J
    Brentzel, J
    Lynch, W
    King, SY
    Brown, T
    Von Hoff, D
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 125 - 125
  • [7] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    H. Sayar
    Z. Shen
    S. J. Lee
    M. Royce
    I. Rabinowitz
    F. Lee
    H. Smith
    S. Eberhardt
    A. Maestas
    H. Lu
    C. Verschraegen
    [J]. Investigational New Drugs, 2009, 27 : 153 - 158
  • [8] Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies
    Chu, Quincy S. C.
    Schwartz, Garry
    de Bono, Johann
    Smith, Deborah A.
    Koch, Kevin M.
    Versola, Melissa J.
    Pandite, Lini
    Arya, Nikita
    Curtright, Jan
    Fleming, Ronald A.
    Ho, Peter T. C.
    Rowinsky, Eric K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3753 - 3758
  • [9] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    Sayar, H.
    Shen, Z.
    Lee, S. J.
    Royce, M.
    Rabinowitz, I.
    Lee, F.
    Smith, H.
    Eberhardt, S.
    Maestas, A.
    Lu, H.
    Verschraegen, C.
    [J]. INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 153 - 158
  • [10] A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
    von Mehren, M.
    Schilder, R. J.
    Cheng, J. D.
    Temmer, E.
    Cardoso, T. M.
    Renshaw, F. G.
    Bayever, E.
    Zannikos, P.
    Yuan, Z.
    Cohen, R. B.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (10) : 1802 - 1809
12345